The article quoted is pointing to the "giant" Tasly Pharma, have I got that right?
Well they might be a giant but we know that's oriented to heart market in China (only China)
That does not give us anything globally for heart and everything else.
A bit of gap filler needed here.
Mesoblast - takeover target?, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.053B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $693.0K | 753.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 50403 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 156741 | 41 |
View Market Depth
| Last trade - 13.47pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |